| VINCRISTINE SULPHATE | |
|---|---|
| Product Name | VINCRISTINE SULPHATE |
| Product Strength | Injection USP 1.0mg / 2.0mg Vial (As Lyophilized) |
| Dosage Form | Oncology Lyophilised Injections |
| Usage | Treatment of acute lymphocytic leukemia (ALL), Hodgkin lymphoma, non-Hodgkin lymphomas, Wilms' tumor, neuroblastoma, rhabdomyosarcoma. Liposomal vincristine is indicated for the treatment of relapsed Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL). |
| Storage Condition | 2 - 8°C |
